{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T03:48:33Z","timestamp":1770522513129,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T00:00:00Z","timestamp":1580688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T00:00:00Z","timestamp":1580688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s11011-020-00538-x","type":"journal-article","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T11:04:01Z","timestamp":1580727841000},"page":"539-548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The effects simultaneous inhibition of dipeptidyl peptidase-4 and P2X7 purinoceptors in an in vivo Parkinson\u2019s disease model"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2416-0335","authenticated-orcid":false,"given":"Nida","family":"Jamali-Raeufy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Mojarrab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tourandokht","family":"Baluchnejadmojarad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Roghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javad","family":"Fahanik-Babaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Goudarzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,3]]},"reference":[{"key":"538_CR1","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/jnc.13087","volume":"133","author":"RM Abdelsalam","year":"2015","unstructured":"Abdelsalam RM, Safar MM (2015) Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NF \u03baB and Nrf2-antioxidant signaling pathways. J Neurochem 133:700\u2013707","journal-title":"J Neurochem"},{"key":"538_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neubiorev.2016.11.022","volume":"73","author":"M Ajami","year":"2017","unstructured":"Ajami M et al (2017) Therapeutic role of sirtuins in neurodegenerative disease and their modulation by polyphenols. Neuroscience & Biobehavioral Reviews 73:39\u201347","journal-title":"Neuroscience & Biobehavioral Reviews"},{"key":"538_CR3","doi-asserted-by":"crossref","unstructured":"Amani H, Arzaghi H, Bayandori M, Dezfuli AS, Pazoki-Toroudi H, Shafiee A, Moradi L (2019a) Controlling cell behavior through the Design of Biomaterial Surfaces: a focus on surface modification techniques advanced materials interfaces:1900572","DOI":"10.1002\/admi.201900572"},{"key":"538_CR4","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.1038\/s41598-019-42633-9","volume":"9","author":"H Amani","year":"2019","unstructured":"Amani H, Habibey R, Shokri F, Hajmiresmail SJ, Akhavan O, Mashaghi A, Pazoki-Toroudi H (2019b) Selenium nanoparticles for targeted stroke therapy through modulation of inflammatory and metabolic signaling. Scientific reports 9:6044","journal-title":"Scientific reports"},{"key":"538_CR5","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.1080\/21691401.2019.1639723","volume":"47","author":"H Amani","year":"2019","unstructured":"Amani H, Kazerooni H, Hassanpoor H, Akbarzadeh A, Pazoki-Toroudi H (2019c) Tailoring synthetic polymeric biomaterials towards nerve tissue engineering: a review. Artificial cells, nanomedicine, and biotechnology 47:3524\u20133539","journal-title":"Artificial cells, nanomedicine, and biotechnology"},{"key":"538_CR6","doi-asserted-by":"publisher","first-page":"8013","DOI":"10.2147\/IJN.S210035","volume":"14","author":"H Amani","year":"2019","unstructured":"Amani H, Mostafavi E, Alebouyeh MR, Arzaghi H, Akbarzadeh A, Pazoki-Toroudi H, Webster TJ (2019d) Would colloidal gold nanocarriers present an effective diagnosis or treatment for ischemic stroke? Int J Nanomedicine 14:8013","journal-title":"Int J Nanomedicine"},{"key":"538_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1021\/acsbiomaterials.8b00658","volume":"5","author":"H Amani","year":"2018","unstructured":"Amani H et al (2018) Three-dimensional graphene foams: synthesis, properties, biocompatibility, biodegradability, and applications in tissue engineering. ACS Biomaterials Science & Engineering 5:193\u2013214","journal-title":"ACS Biomaterials Science & Engineering"},{"key":"538_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejphar.2017.03.002","volume":"801","author":"T Baluchnejadmojarad","year":"2017","unstructured":"Baluchnejadmojarad T, Jamali-Raeufy N, Zabihnejad S, Rabiee N, Roghani M (2017) Troxerutin exerts neuroprotection in 6-hydroxydopamine lesion rat model of Parkinson\u2019s disease: possible involvement of PI3K\/ER\u03b2 signaling. Eur J Pharmacol 801:72\u201378","journal-title":"Eur J Pharmacol"},{"key":"538_CR9","doi-asserted-by":"crossref","unstructured":"Baluchnejadmojarad T, Roghani M, Nadoushan MRJ, Bagheri M (2009) Neuroprotective effect of genistein in 6-hydroxydopamine hemi-parkinsonian rat model Phytotherapy research: an international journal devoted to pharmacological and toxicological evaluation of natural product derivatives 23:132-135","DOI":"10.1002\/ptr.2564"},{"key":"538_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, R\u00fcb U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell and tissue research 318:121\u2013134","journal-title":"Cell and tissue research"},{"key":"538_CR11","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/s12035-018-1274-7","volume":"56","author":"A Cruces-Sande","year":"2019","unstructured":"Cruces-Sande A, Rodr\u00edguez-P\u00e9rez AI, Herbello-Hermelo P, Bermejo-Barrera P, M\u00e9ndez-\u00c1lvarez E, Labandeira-Garc\u00eda JL, Soto-Otero R (2019) Copper increases brain oxidative stress and enhances the ability of 6-Hydroxydopamine to cause dopaminergic degeneration in a rat model of Parkinson\u2019s disease. Mol Neurobiol 56:2845\u20132854","journal-title":"Mol Neurobiol"},{"key":"538_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1006\/exnr.2002.7891","volume":"175","author":"R Deumens","year":"2002","unstructured":"Deumens R, Blokland A, Prickaerts J (2002) Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 175:303\u2013317","journal-title":"Exp Neurol"},{"key":"538_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.yexmp.2019.05.002","volume":"109","author":"H Ge","year":"2019","unstructured":"Ge H, Yan Z, Zhu H, Zhao H (2019) MiR-410 exerts neuroprotective effects in a cellular model of Parkinson's disease induced by 6-hydroxydopamine via inhibiting the PTEN\/AKT\/mTOR signaling pathway. Experimental and molecular pathology 109:16\u201324","journal-title":"Experimental and molecular pathology"},{"key":"538_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neulet.2018.03.037","volume":"675","author":"L Geng","year":"2018","unstructured":"Geng L, Zhang T, Liu W, Chen Y (2018) miR-494-3p modulates the progression of in vitro and in vivo Parkinson\u2019s disease models by targeting SIRT3. Neuroscience letters 675:23\u201330","journal-title":"Neuroscience letters"},{"key":"538_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009199","volume":"5","author":"HS Ghosh","year":"2010","unstructured":"Ghosh HS, McBurney M, Robbins PD (2010) SIRT1 negatively regulates the mammalian target of rapamycin. PLoS One 5:e9199","journal-title":"PLoS One"},{"key":"538_CR16","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1111\/j.1471-4159.2007.05115.x","volume":"104","author":"M Gomez-Lazaro","year":"2008","unstructured":"Gomez-Lazaro M, Galindo MF, Concannon CG, Segura MF, Fernandez-Gomez FJ, Llecha N, Comella JX, Prehn JH, Jordan J (2008) 6-Hydroxydopamine activates the mitochondrial apoptosis pathway through p38 MAPK-mediated, p53-independent activation of Bax and PUMA. J Neurochem 104:1599\u20131612","journal-title":"J Neurochem"},{"key":"538_CR17","doi-asserted-by":"publisher","first-page":"13276","DOI":"10.1038\/s41598-018-31517-z","volume":"8","author":"S Hall","year":"2018","unstructured":"Hall S, Janelidze S, Surova Y, Widner H, Zetterberg H, Hansson O (2018) Cerebrospinal fluid concentrations of inflammatory markers in Parkinson\u2019s disease and atypical parkinsonian disorders. Scientific reports 8:13276","journal-title":"Scientific reports"},{"key":"538_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4161\/cc.22912","volume":"12","author":"P Hasty","year":"2013","unstructured":"Hasty P, Sharp ZD, Curiel TJ, Campisi J (2013) mTORC1 and p53: clash of the gods? Cell Cycle 12:20\u201325","journal-title":"Cell Cycle"},{"key":"538_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nm.2558","volume":"18","author":"M Jiang","year":"2012","unstructured":"Jiang M et al (2012) Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets. Nat Med 18:153","journal-title":"Nat Med"},{"key":"538_CR20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10571-015-0230-6","volume":"36","author":"Z Kiasalari","year":"2016","unstructured":"Kiasalari Z, Baluchnejadmojarad T, Roghani M (2016) Hypericum perforatum hydroalcoholic extract mitigates motor dysfunction and is neuroprotective in intrastriatal 6-Hydroxydopamine rat model of Parkinson\u2019s disease. Cell Mol Neurobiol 36:521\u2013530","journal-title":"Cell Mol Neurobiol"},{"key":"538_CR21","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1038\/sj.emboj.7601758","volume":"26","author":"D Kim","year":"2007","unstructured":"Kim D et al (2007) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 26:3169\u20133179","journal-title":"EMBO J"},{"key":"538_CR22","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1056\/NEJM199810153391607","volume":"339","author":"AE Lang","year":"1998","unstructured":"Lang AE, Lozano AM (1998) Parkinson's disease New England Journal of Medicine 339:1130\u20131143","journal-title":"Parkinson's disease New England Journal of Medicine"},{"key":"538_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neulet.2018.03.041","volume":"675","author":"W Li","year":"2018","unstructured":"Li W, Jiang Y, Wang Y, Yang S, Bi X, Pan X, Ma A (2018) MiR-181b regulates autophagy in a model of Parkinson\u2019s disease by targeting the PTEN\/Akt\/mTOR signaling pathway. Neurosci Lett 675:83\u201388","journal-title":"Neurosci Lett"},{"key":"538_CR24","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s11064-014-1507-8","volume":"40","author":"L Liu","year":"2015","unstructured":"Liu L, Peritore C, Ginsberg J, Kayhan M, Donmez G (2015) SIRT3 attenuates MPTP-induced nigrostriatal degeneration via enhancing mitochondrial antioxidant capacity. Neurochemical research 40:600\u2013608","journal-title":"Neurochemical research"},{"key":"538_CR25","first-page":"019","volume":"4","author":"I Martins","year":"2017","unstructured":"Martins I (2017a) Nutrition therapy regulates caffeine metabolism with relevance to NAFLD and induction of type 3 diabetes. J diabetes Metab Disord 4:019","journal-title":"J diabetes Metab Disord"},{"key":"538_CR26","first-page":"24","volume":"3","author":"IJ Martins","year":"2017","unstructured":"Martins IJ (2017b) Single gene inactivation with implications to diabetes and multiple organ dysfunction syndrome. J Clin Epigenet 3:24","journal-title":"J Clin Epigenet"},{"key":"538_CR27","doi-asserted-by":"crossref","unstructured":"Obeso JA, Olanow CW, Nutt JG (2000) Levodopa motor complications in Parkinson's disease. Elsevier,","DOI":"10.1016\/S1471-1931(00)00031-8"},{"key":"538_CR28","unstructured":"Paxinos G, Franklin KB (2019) Paxinos and Franklin's the mouse brain in stereotaxic coordinates. Academic press,"},{"key":"538_CR29","unstructured":"Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic New York"},{"key":"538_CR30","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1161\/CIRCRESAHA.113.300536","volume":"114","author":"VB Pillai","year":"2014","unstructured":"Pillai VB, Sundaresan NR, Gupta MP (2014) Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging. Circulation research 114:368\u2013378","journal-title":"Circulation research"},{"key":"538_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0031-9384(02)00753-9","volume":"76","author":"M Roghani","year":"2002","unstructured":"Roghani M, Behzadi G, Baluchnejadmojarad T (2002) Efficacy of elevated body swing test in the early model of Parkinson's disease in rat. Physiology & behavior 76:507\u2013510","journal-title":"Physiology & behavior"},{"key":"538_CR32","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM (2017) mTOR signaling in growth, metabolism, and disease. Cell 168:960\u2013976","journal-title":"Cell"},{"key":"538_CR33","first-page":"689","volume":"18","author":"R Schwarting","year":"1997","unstructured":"Schwarting R, Huston J (1997) Behavioral and neurochemical dynamics of neurotoxic meso-striatal dopamine lesions. Neurotoxicology 18:689\u2013708","journal-title":"Neurotoxicology"},{"key":"538_CR34","doi-asserted-by":"crossref","unstructured":"Singh P, Hanson PS, Morris CM (2017) SIRT1 ameliorates oxidative stress induced neural cell death and is down-regulated in Parkinson\u2019s disease. BMC neuroscience 18:\u201346","DOI":"10.1186\/s12868-017-0364-1"},{"key":"538_CR35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S1097-2765(01)00323-9","volume":"8","author":"V Stambolic","year":"2001","unstructured":"Stambolic V et al (2001) Regulation of PTEN transcription by p53. Molecular cell 8:317\u2013325","journal-title":"Molecular cell"},{"key":"538_CR36","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/jnc.13691","volume":"139","author":"S Sveinbjornsdottir","year":"2016","unstructured":"Sveinbjornsdottir S (2016) The clinical symptoms of Parkinson's disease. J Neurochem 139:318\u2013324","journal-title":"J Neurochem"},{"key":"538_CR37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/cbin.10864","volume":"42","author":"CY Wang","year":"2018","unstructured":"Wang CY, Sun ZN, Wang MX, Zhang C (2018) SIRT1 mediates salidroside-elicited protective effects against MPP+-induced apoptosis and oxidative stress in SH-SY5Y cells: involvement in suppressing MAPK pathways. Cell biology international 42:84\u201394","journal-title":"Cell biology international"},{"key":"538_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neuroscience.2014.11.045","volume":"286","author":"Q Wang","year":"2015","unstructured":"Wang Q, Li L, Li C, Pei Z, Zhou M, Li N (2015) SIRT3 protects cells from hypoxia via PGC-1\u03b1-and MnSOD-dependent pathways. Neuroscience 286:109\u2013121","journal-title":"Neuroscience"},{"key":"538_CR39","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3892\/mmr.2016.6070","volume":"15","author":"XH Wang","year":"2017","unstructured":"Wang XH, Xie X, Luo XG, Shang H, He ZY (2017) Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson's disease. Mol Med Rep 15:768\u2013776","journal-title":"Mol Med Rep"},{"key":"538_CR40","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neulet.2019.02.038","volume":"701","author":"Z Wang","year":"2019","unstructured":"Wang Z, Sun L, Jia K, Wang H, Wang X (2019) miR-9-5p modulates the progression of Parkinson\u2019s disease by targeting SIRT1. Neuroscience letters 701:226\u2013233","journal-title":"Neuroscience letters"},{"key":"538_CR41","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.pneurobio.2011.09.001","volume":"95","author":"F Zhang","year":"2011","unstructured":"Zhang F, Wang S, Gan L, Vosler PS, Gao Y, Zigmond MJ, Chen J (2011) Protective effects and mechanisms of sirtuins in the nervous system. Progress in neurobiology 95:373\u2013395","journal-title":"Progress in neurobiology"},{"key":"538_CR42","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s11064-016-1892-2","volume":"41","author":"J-Y Zhang","year":"2016","unstructured":"Zhang J-Y, Deng Y-N, Zhang M, Su H, Qu Q-M (2016) SIRT3 acts as a neuroprotective agent in rotenone-induced Parkinson cell model. Neurochemical research 41:1761\u20131773","journal-title":"Neurochemical research"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-020-00538-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11011-020-00538-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-020-00538-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:25:17Z","timestamp":1612225517000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11011-020-00538-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["538"],"URL":"https:\/\/doi.org\/10.1007\/s11011-020-00538-x","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,3]]},"assertion":[{"value":"9 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}